These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23777480)

  • 1. Exercise to preserve beta cell function in recent-onset type 1 diabetes mellitus (EXTOD)--a study protocol for a pilot randomized controlled trial.
    Lascar N; Kennedy A; Jackson N; Daley A; Dowswell G; Thompson D; Stokes K; Greenfield S; Holder R; Andrews R; Narendran P
    Trials; 2013 Jun; 14():180. PubMed ID: 23777480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exercise to preserve β-cell function in recent-onset Type 1 diabetes mellitus (EXTOD) - a randomized controlled pilot trial.
    Narendran P; Jackson N; Daley A; Thompson D; Stokes K; Greenfield S; Charlton M; Curran M; Solomon TPJ; Nouwen A; Lee SI; Cooper AR; Mostazir M; Taylor RS; Kennedy A; Andrews RC
    Diabet Med; 2017 Nov; 34(11):1521-1531. PubMed ID: 28905421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of different doses of exercise on pancreatic β-cell function in patients with newly diagnosed type 2 diabetes: study protocol for and rationale behind the "DOSE-EX" multi-arm parallel-group randomised clinical trial.
    Lyngbaek MPP; Legaard GE; Bennetsen SL; Feineis CS; Rasmussen V; Moegelberg N; Brinkløv CF; Nielsen AB; Kofoed KS; Lauridsen CA; Ewertsen C; Poulsen HE; Christensen R; Van Hall G; Karstoft K; Solomon TPJ; Ellingsgaard H; Almdal TP; Pedersen BK; Ried-Larsen M
    Trials; 2021 Apr; 22(1):244. PubMed ID: 33794975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin secretion measured by stimulated C-peptide in long-established Type 1 diabetes in the Diabetes Control and Complications Trial (DCCT)/ Epidemiology of Diabetes Interventions and Complications (EDIC) cohort: a pilot study.
    McGee P; Steffes M; Nowicki M; Bayless M; Gubitosi-Klug R; Cleary P; Lachin J; Palmer J;
    Diabet Med; 2014 Oct; 31(10):1264-8. PubMed ID: 24836354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mobile Exergaming for Health-Effects of a serious game application for smartphones on physical activity and exercise adherence in type 2 diabetes mellitus-study protocol for a randomized controlled trial.
    Höchsmann C; Walz SP; Schäfer J; Holopainen J; Hanssen H; Schmidt-Trucksäss A
    Trials; 2017 Mar; 18(1):103. PubMed ID: 28264717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teplizumab and β-Cell Function in Newly Diagnosed Type 1 Diabetes.
    Ramos EL; Dayan CM; Chatenoud L; Sumnik Z; Simmons KM; Szypowska A; Gitelman SE; Knecht LA; Niemoeller E; Tian W; Herold KC;
    N Engl J Med; 2023 Dec; 389(23):2151-2161. PubMed ID: 37861217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wristband Accelerometers to motiVate arm Exercise after Stroke (WAVES): study protocol for a pilot randomized controlled trial.
    Moore SA; Da Silva R; Balaam M; Brkic L; Jackson D; Jamieson D; Ploetz T; Rodgers H; Shaw L; van Wijck F; Price C
    Trials; 2016 Oct; 17(1):508. PubMed ID: 27769310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of a self-management intervention with personalised genetic and lifestyle-related risk information on coronary heart disease and diabetes-related risk in type 2 diabetes (CoRDia): study protocol for a randomised controlled trial.
    Davies AK; McGale N; Humphries SE; Hirani SP; Beaney KE; Bappa DA; McCabe JG; Newman SP
    Trials; 2015 Dec; 16():547. PubMed ID: 26631181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of the DEXLIFE 'self-selected' lifestyle intervention aimed at improving insulin sensitivity in people at risk of developing type 2 diabetes: study protocol for a randomised controlled trial.
    O'Donoghue GM; Kennedy A; Andersen GS; Durkan E; Thybo T; Sinnott M; Nolan JJ; O'Gorman DJ
    Trials; 2015 Nov; 16():529. PubMed ID: 26581687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attitudes and barriers to exercise in adults with a recent diagnosis of type 1 diabetes: a qualitative study of participants in the Exercise for Type 1 Diabetes (EXTOD) study.
    Kennedy A; Narendran P; Andrews RC; Daley A; Greenfield SM;
    BMJ Open; 2018 Jan; 8(1):e017813. PubMed ID: 29371269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-dependent decline of β-cell function in type 1 diabetes after diagnosis: a multi-centre longitudinal study.
    Barker A; Lauria A; Schloot N; Hosszufalusi N; Ludvigsson J; Mathieu C; Mauricio D; Nordwall M; Van der Schueren B; Mandrup-Poulsen T; Scherbaum WA; Weets I; Gorus FK; Wareham N; Leslie RD; Pozzilli P
    Diabetes Obes Metab; 2014 Mar; 16(3):262-7. PubMed ID: 24118704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved preservation of residual beta cell function by atorvastatin in patients with recent onset type 1 diabetes and high CRP levels (DIATOR trial).
    Strom A; Kolb H; Martin S; Herder C; Simon MC; Koenig W; Heise T; Heinemann L; Roden M; Schloot NC;
    PLoS One; 2012; 7(3):e33108. PubMed ID: 22448235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The time has come to test the beta cell preserving effects of exercise in patients with new onset type 1 diabetes.
    Narendran P; Solomon TP; Kennedy A; Chimen M; Andrews RC
    Diabetologia; 2015 Jan; 58(1):10-8. PubMed ID: 25367458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial.
    von Herrath M; Bain SC; Bode B; Clausen JO; Coppieters K; Gaysina L; Gumprecht J; Hansen TK; Mathieu C; Morales C; Mosenzon O; Segel S; Tsoukas G; Pieber TR;
    Lancet Diabetes Endocrinol; 2021 Apr; 9(4):212-224. PubMed ID: 33662334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No effect of the altered peptide ligand NBI-6024 on beta-cell residual function and insulin needs in new-onset type 1 diabetes.
    Walter M; Philotheou A; Bonnici F; Ziegler AG; Jimenez R;
    Diabetes Care; 2009 Nov; 32(11):2036-40. PubMed ID: 19690081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of an aquatic physical exercise program on glycemic control and perinatal outcomes of gestational diabetes: study protocol for a randomized controlled trial.
    da Silva JR; Borges PS; Agra KF; Pontes IA; Alves JG
    Trials; 2013 Nov; 14():390. PubMed ID: 24245914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Qualitative study of barriers to clinical trial retention in adults with recently diagnosed type 1 diabetes.
    Henshall C; Narendran P; Andrews RC; Daley A; Stokes KA; Kennedy A; Greenfield S
    BMJ Open; 2018 Jul; 8(7):e022353. PubMed ID: 30018100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structured, intensive education maximising engagement, motivation and long-term change for children and young people with diabetes: a cluster randomised controlled trial with integral process and economic evaluation - the CASCADE study.
    Christie D; Thompson R; Sawtell M; Allen E; Cairns J; Smith F; Jamieson E; Hargreaves K; Ingold A; Brooks L; Wiggins M; Oliver S; Jones R; Elbourne D; Santos A; Wong IC; O'Neill S; Strange V; Hindmarsh P; Annan F; Viner R
    Health Technol Assess; 2014 Mar; 18(20):1-202. PubMed ID: 24690402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-cell replenishment: Possible curative approaches for diabetes mellitus.
    Rathwa N; Patel R; Palit SP; Parmar N; Rana S; Ansari MI; Ramachandran AV; Begum R
    Nutr Metab Cardiovasc Dis; 2020 Oct; 30(11):1870-1881. PubMed ID: 32994121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel therapies in the management of type I diabetes mellitus.
    Ludvigsson J
    Panminerva Med; 2012 Dec; 54(4):257-70. PubMed ID: 23123577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.